Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 1
1987 1
1988 4
1989 1
1990 2
1991 2
1992 6
1993 3
1994 2
1995 7
1996 2
1997 8
1998 7
1999 6
2000 14
2001 8
2002 14
2003 15
2004 7
2005 7
2006 7
2007 8
2008 11
2009 2
2010 3
2011 7
2012 4
2013 5
2014 4
2015 3
2016 8
2017 11
2018 6
2019 2
2020 4
2021 3
2022 4
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Bardia A, Hurvitz SA, Tolaney SM, Loirat D, Punie K, Oliveira M, Brufsky A, Sardesai SD, Kalinsky K, Zelnak AB, Weaver R, Traina T, Dalenc F, Aftimos P, Lynce F, Diab S, Cortés J, O'Shaughnessy J, Diéras V, Ferrario C, Schmid P, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo MS, Itri LM, Rugo HS; ASCENT Clinical Trial Investigators. Bardia A, et al. Among authors: piccart mj. N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485. N Engl J Med. 2021. PMID: 33882206 Clinical Trial.
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer.
Rugo HS, Tolaney SM, Loirat D, Punie K, Bardia A, Hurvitz SA, O'Shaughnessy J, Cortés J, Diéras V, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo M, Itri LM, Kalinsky K. Rugo HS, et al. Among authors: piccart mj. NPJ Breast Cancer. 2022 Aug 29;8(1):98. doi: 10.1038/s41523-022-00467-1. NPJ Breast Cancer. 2022. PMID: 36038616 Free PMC article.
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
Aftimos P, Oliveira M, Irrthum A, Fumagalli D, Sotiriou C, Gal-Yam EN, Robson ME, Ndozeng J, Di Leo A, Ciruelos EM, de Azambuja E, Viale G, Scheepers ED, Curigliano G, Bliss JM, Reis-Filho JS, Colleoni M, Balic M, Cardoso F, Albanell J, Duhem C, Marreaud S, Romagnoli D, Rojas B, Gombos A, Wildiers H, Guerrero-Zotano A, Hall P, Bonetti A, Larsson KF, Degiorgis M, Khodaverdi S, Greil R, Sverrisdóttir Á, Paoli M, Seyll E, Loibl S, Linderholm B, Zoppoli G, Davidson NE, Johannsson OT, Bedard PL, Loi S, Knox S, Cameron DA, Harbeck N, Montoya ML, Brandão M, Vingiani A, Caballero C, Hilbers FS, Yates LR, Benelli M, Venet D, Piccart MJ. Aftimos P, et al. Among authors: piccart mj. Cancer Discov. 2021 Nov;11(11):2796-2811. doi: 10.1158/2159-8290.CD-20-1647. Epub 2021 Jun 28. Cancer Discov. 2021. PMID: 34183353 Free PMC article.
Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer.
Loibl S, Loirat D, Tolaney SM, Punie K, Oliveira M, Rugo HS, Bardia A, Hurvitz SA, Brufsky AM, Kalinsky K, Cortés J, O'Shaughnessy JA, Dieras V, Carey LA, Gianni L, Gharaibeh M, Preger L, Phan S, Chang L, Shi L, Piccart MJ. Loibl S, et al. Among authors: piccart mj. Eur J Cancer. 2023 Jan;178:23-33. doi: 10.1016/j.ejca.2022.10.003. Epub 2022 Oct 18. Eur J Cancer. 2023. PMID: 36379186 Free PMC article. Clinical Trial.
Neoadjuvant treatment: the future of patients with breast cancer.
Reyal F, Hamy AS, Piccart MJ. Reyal F, et al. Among authors: piccart mj. ESMO Open. 2018 May 17;3(4):e000371. doi: 10.1136/esmoopen-2018-000371. eCollection 2018. ESMO Open. 2018. PMID: 29862051 Free PMC article. No abstract available.
Adjuvant systemic therapy for breast cancer.
Roy JA, Piccart MJ. Roy JA, et al. Among authors: piccart mj. Curr Opin Oncol. 1995 Nov;7(6):517-22. doi: 10.1097/00001622-199511000-00007. Curr Opin Oncol. 1995. PMID: 8547399 Review.
[Breast cancer and herceptin].
Cornez N, Piccart MJ. Cornez N, et al. Among authors: piccart mj. Bull Cancer. 2000 Nov;87(11):847-58. Bull Cancer. 2000. PMID: 11125293 Free article. Review. French.
New cytostatic drugs in ovarian cancer.
Hansen HH, Eisenhauer EA, Hansen M, Neijt JP, Piccart MJ, Sessa C, Thigpen JT. Hansen HH, et al. Among authors: piccart mj. Ann Oncol. 1993;4 Suppl 4:63-70. doi: 10.1093/annonc/4.suppl_4.s63. Ann Oncol. 1993. PMID: 7906138 Review.
207 results